Susquehanna International Group
SLNO

Susquehanna International Group’s Soleno Therapeutics SLNO Stock Holding History

Susquehanna International Group’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.1M Buy
721,200
+363,900
+102% +$14.3M ﹤0.01% 1981
2025
Q4 		$16.5M Sell
357,300
-64,000
-15% -$3.51M ﹤0.01% 2413
2025
Q3 		$28.5M Sell
421,300
-338,600
-45% -$25.1M ﹤0.01% 1847
2025
Q2 		$63.7M Buy
759,900
+452,800
+147% +$33.9M 0.01% 1006
2025
Q1 		$21.9M Sell
307,100
-1,203,900
-80% -$58.6M ﹤0.01% 1666
2024
Q4 		$67.9M Buy
1,511,000
+1,441,400
+2,071% +$74.7M 0.01% 921
2024
Q3 		$3.51M Sell
69,600
-42,800
-38% -$2.05M ﹤0.01% 4244
2024
Q2 		$4.59M Buy
112,400
+93,400
+492% +$3.96M ﹤0.01% 3590
2024
Q1 		$813K Sell
19,000
-38,400
-67% -$1.74M ﹤0.01% 7374
2023
Q4 		$2.31M Buy
+57,400
New +$1.63M ﹤0.01% 5068
2022
Q4 		– Sell
-14,500
Closed -$24K – 13574
2022
Q3 		$24K Buy
14,500
+13,533
+1,399% +$33K ﹤0.01% 12535
2022
Q2 		$3K Buy
967
+34
+4% +$94 ﹤0.01% 12662
2022
Q1 		$3K Sell
933
-1,254
-57% -$6.49K ﹤0.01% 12854
2021
Q4 		$13K Sell
2,187
-7,286
-77% -$76.4K ﹤0.01% 12899
2021
Q3 		$131K Sell
9,473
-3,514
-27% -$49K ﹤0.01% 11888
2021
Q2 		$222K Buy
12,987
+8,447
+186% +$143K ﹤0.01% 11382
2021
Q1 		$86K Buy
4,540
+3,360
+285% +$108K ﹤0.01% 11908
2020
Q4 		$34K Sell
1,180
-147
-11% -$4.24K ﹤0.01% 10822
2020
Q3 		$50K Buy
1,327
+547
+70% +$16K ﹤0.01% 10200
2020
Q2 		$26K Buy
+780
New +$33.8K ﹤0.01% 9888

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Susquehanna International Group's SLNO Position: Q1 2026 in Review

Susquehanna International Group increased its Soleno Therapeutics (SLNO) stake by 125% in Q1 2026, buying an estimated $12M and bringing the position to 549,877 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

Susquehanna International Group first reported a position in SLNO in Q1 2017 and has held it in 23 quarters since. The position peaked at $34.6M in Q2 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Susquehanna International Group held 549,877 shares of Soleno Therapeutics worth $18.4M as of Q1 2026.
  • Susquehanna International Group bought 305,519 Soleno Therapeutics shares in Q1 2026, an estimated $12M.
  • Soleno Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2336 holding.
  • Susquehanna International Group first reported a position in Soleno Therapeutics in Q1 2017 and has held it in 23 quarters since.
  • Susquehanna International Group's Soleno Therapeutics position peaked at $34.6M in Q2 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.